✦ LIBER ✦

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

✍ Scribed by McKeage, Mark J.; Reck, Martin; Jameson, Michael B.; Rosenthal, Mark A.; Gibbs, David; Mainwaring, Paul N.; Freitag, Lutz; Sullivan, Richard; Von Pawel, Joachim

Book ID: 119320163
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 250 KB
Volume: 65
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.03.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II study of ASA404 comb

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

✍ McKeage, M J; Von Pawel, J; Reck, M; Jameson, M B; Rosenthal, M A; Sullivan, R; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 174 KB

A phase II study of weekly paclitaxel an

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Andre Michel Kallab; Yasolatha Nalamolu; Paul Maclyn Dainer; Anand Prasad Jillel 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 73 KB